IL101353A0 - Pharmaceutical compositions for treating diabetes - Google Patents

Pharmaceutical compositions for treating diabetes

Info

Publication number
IL101353A0
IL101353A0 IL101353A IL10135392A IL101353A0 IL 101353 A0 IL101353 A0 IL 101353A0 IL 101353 A IL101353 A IL 101353A IL 10135392 A IL10135392 A IL 10135392A IL 101353 A0 IL101353 A0 IL 101353A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
treating diabetes
insulin
arresting
retarding
Prior art date
Application number
IL101353A
Other languages
English (en)
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/792,105 external-priority patent/US5321009A/en
Application filed by American Home Prod filed Critical American Home Prod
Publication of IL101353A0 publication Critical patent/IL101353A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
IL101353A 1991-04-03 1992-03-24 Pharmaceutical compositions for treating diabetes IL101353A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67970691A 1991-04-03 1991-04-03
US07/792,105 US5321009A (en) 1991-04-03 1991-11-14 Method of treating diabetes

Publications (1)

Publication Number Publication Date
IL101353A0 true IL101353A0 (en) 1992-11-15

Family

ID=27102296

Family Applications (1)

Application Number Title Priority Date Filing Date
IL101353A IL101353A0 (en) 1991-04-03 1992-03-24 Pharmaceutical compositions for treating diabetes

Country Status (19)

Country Link
EP (1) EP0507555B1 (xx)
JP (1) JP2535119B2 (xx)
AT (1) ATE139120T1 (xx)
AU (1) AU652037B2 (xx)
CA (1) CA2064678A1 (xx)
CZ (1) CZ282733B6 (xx)
DE (1) DE69211406T2 (xx)
DK (1) DK0507555T3 (xx)
ES (1) ES2089395T3 (xx)
GR (1) GR3020316T3 (xx)
HK (1) HK108797A (xx)
HU (1) HUT60626A (xx)
IE (1) IE74884B1 (xx)
IL (1) IL101353A0 (xx)
MX (1) MX9201513A (xx)
NO (1) NO921279L (xx)
NZ (1) NZ242190A (xx)
SG (1) SG43075A1 (xx)
SK (1) SK279180B6 (xx)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378696A (en) * 1990-09-19 1995-01-03 American Home Products Corporation Rapamycin esters
US5177203A (en) * 1992-03-05 1993-01-05 American Home Products Corporation Rapamycin 42-sulfonates and 42-(N-carboalkoxy) sulfamates useful as immunosuppressive agents
US5256790A (en) * 1992-08-13 1993-10-26 American Home Products Corporation 27-hydroxyrapamycin and derivatives thereof
CA2106034A1 (en) * 1992-09-24 1994-03-25 Ralph J. Russo 21-norrapamycin
US5480989A (en) * 1992-10-13 1996-01-02 American Home Products Corporation Carbamates of rapamycin
US5302584A (en) * 1992-10-13 1994-04-12 American Home Products Corporation Carbamates of rapamycin
US5480988A (en) * 1992-10-13 1996-01-02 American Home Products Corporation Carbamates of rapamycin
US5434260A (en) * 1992-10-13 1995-07-18 American Home Products Corporation Carbamates of rapamycin
US5489680A (en) * 1992-10-13 1996-02-06 American Home Products Corporation Carbamates of rapamycin
US5349060A (en) * 1993-01-07 1994-09-20 American Home Products Corporation Rapamycin 31-ester with N,N-dimethylglycine derivatives useful as immunosuppressive agents
US5252579A (en) * 1993-02-16 1993-10-12 American Home Products Corporation Macrocyclic immunomodulators
US7279561B1 (en) 1993-04-23 2007-10-09 Wyeth Anti-rapamycin monoclonal antibodies
ES2295093T3 (es) 1993-04-23 2008-04-16 Wyeth Conjugados y anticuerpos de rapamicina.
US5504091A (en) * 1993-04-23 1996-04-02 American Home Products Corporation Biotin esters of rapamycin
US5387680A (en) * 1993-08-10 1995-02-07 American Home Products Corporation C-22 ring stabilized rapamycin derivatives
US5391730A (en) * 1993-10-08 1995-02-21 American Home Products Corporation Phosphorylcarbamates of rapamycin and oxime derivatives thereof
US5373014A (en) * 1993-10-08 1994-12-13 American Home Products Corporation Rapamycin oximes
US5378836A (en) * 1993-10-08 1995-01-03 American Home Products Corporation Rapamycin oximes and hydrazones
US5385908A (en) * 1993-11-22 1995-01-31 American Home Products Corporation Hindered esters of rapamycin
US5385909A (en) * 1993-11-22 1995-01-31 American Home Products Corporation Heterocyclic esters of rapamycin
US5385910A (en) * 1993-11-22 1995-01-31 American Home Products Corporation Gem-distributed esters of rapamycin
US5389639A (en) * 1993-12-29 1995-02-14 American Home Products Company Amino alkanoic esters of rapamycin
US5525610A (en) * 1994-03-31 1996-06-11 American Home Products Corporation 42-Epi-rapamycin and pharmaceutical compositions thereof
US5362718A (en) 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
US5496831A (en) * 1994-05-13 1996-03-05 The General Hospital Corporation Inhibition of insulin-induced adiposis
US5463048A (en) * 1994-06-14 1995-10-31 American Home Products Corporation Rapamycin amidino carbamates
US5491231A (en) * 1994-11-28 1996-02-13 American Home Products Corporation Hindered N-oxide esters of rapamycin
US5563145A (en) * 1994-12-07 1996-10-08 American Home Products Corporation Rapamycin 42-oximes and hydroxylamines
US5561138A (en) * 1994-12-13 1996-10-01 American Home Products Corporation Method of treating anemia
US5496832A (en) * 1995-03-09 1996-03-05 American Home Products Corporation Method of treating cardiac inflammatory disease
FR2736550B1 (fr) 1995-07-14 1998-07-24 Sandoz Sa Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule
TW427904B (en) * 1995-12-07 2001-04-01 American Home Prod Neuroprotective agents
US5780462A (en) * 1995-12-27 1998-07-14 American Home Products Corporation Water soluble rapamycin esters
US5922730A (en) * 1996-09-09 1999-07-13 American Home Products Corporation Alkylated rapamycin derivatives
US6015809A (en) * 1998-08-17 2000-01-18 American Home Products Corporation Photocyclized rapamycin
IL154925A0 (en) * 2000-09-14 2003-10-31 Beth Israel Hospital Modulation of il-2 and il-15-mediated t cell responses
DE60329724D1 (de) 2002-06-07 2009-11-26 Waratah Pharmaceuticals Inc Methoden und Kompositionen um Diabetes zu behandeln

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100899A (en) * 1989-06-06 1992-03-31 Roy Calne Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
US5023263A (en) * 1990-08-09 1991-06-11 American Home Products Corporation 42-oxorapamycin

Also Published As

Publication number Publication date
EP0507555A1 (en) 1992-10-07
HK108797A (en) 1997-08-22
ES2089395T3 (es) 1996-10-01
HU9201113D0 (en) 1992-06-29
NO921279L (no) 1992-10-05
NO921279D0 (no) 1992-04-02
SK279180B6 (sk) 1998-07-08
ATE139120T1 (de) 1996-06-15
JP2535119B2 (ja) 1996-09-18
DE69211406D1 (de) 1996-07-18
IE74884B1 (en) 1997-08-13
AU1395792A (en) 1992-10-08
NZ242190A (en) 1997-06-24
GR3020316T3 (en) 1996-09-30
MX9201513A (es) 1993-04-01
CZ97292A3 (en) 1993-09-15
EP0507555B1 (en) 1996-06-12
AU652037B2 (en) 1994-08-11
DK0507555T3 (da) 1996-07-01
DE69211406T2 (de) 1996-11-28
IE921055A1 (en) 1992-10-07
CA2064678A1 (en) 1992-10-04
JPH0597688A (ja) 1993-04-20
CZ282733B6 (cs) 1997-09-17
HUT60626A (en) 1992-10-28
SK97292A3 (en) 1994-11-09
SG43075A1 (en) 1997-10-17

Similar Documents

Publication Publication Date Title
IL101353A0 (en) Pharmaceutical compositions for treating diabetes
NO164410C (no) Drivanordning med laasemekanisme for heisdoer.
HU9400350D0 (en) Retard peptides
NO902840D0 (no) Middel for transdermal applikasjon som inneholder gestoden
GR3018890T3 (en) Medicament dispensing device.
EP0670213A3 (xx)
EP0435443A3 (en) Use of 15-keto-prostaglandin compound for improvement of encephalic function
GB2223168B (en) Pharmaceutical composition comprising inositoltrisphosphate for the treatment of complications of diabetes
EP0601077A4 (en) Medical syringe with needle-retracting mechanism.
EP0455448A3 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
ZA927028B (en) Safety syringe.
GB2245914B (en) Orifice well safety valve with release mechanism
EP0430552A3 (en) Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
HUT62997A (en) Lighter with safety mechanism
EP0612728A3 (en) Anisomycin derivatives and anticancer agents, antifungal agents and antiprotozoan agents containing them.
GR3002305T3 (en) Fungicidal mixtures with prochloraz
EP0646384A3 (en) Safety syringe.
GB9108780D0 (en) Mechanism for lipstick-holder case or the like
CA67045S (en) Games accessory for use with marbles, counters or the like
GB9122766D0 (en) Medicament composition
GB9103589D0 (en) Safety syringe
GB9017005D0 (en) Specification for safety valve construction
NO913265D0 (no) Sikkerhetsanordning for bil.